Phone +49 221 478-87724
Fax +49 221 478-87728
We speak German, English, Russian, Arabic, Kazakh.
Welcome to the Department of Ophthalmology at the University Hospital Cologne
We welcome you to the web-presentation.
The Department of Ophthalmology at the University Hospital Cologne is one of the largest ophthalmological centres in Germany. The department has a long standing history of excellence in anterior and posterior segment diseases of the eye.
Our main clinical areas of specialisation are:
- Cornea and modern corneal transplant-surgery (DMEK, DASEK, DALK, penetrating keratoplasty, amniotic-membran-transplantation, refractiv and curative corneal laser treatments etc.)
- Cataract surgery (standard and special intraocular lenses, toric lenses, multifocallenses etc.)
- Glaucoma and glaucoma surgery (penetrating and non-penetrating techniques, canaloplasty, trabectome etc.)
- Vitreoretinal surgery and AMD (Department of vitreoretinal surgery; Prof. Dr. T. Krohne)
- Strabismology and neuroophthalmology (Section head: PD Dr. Neugebauer, Dr. Fricke)
- Ocular oncology and adjuvant therapies (in cooperation with CIO, Centre of Integrated Oncology Cologne)
Our main areas of research are the modulation of inflammatory diseases in the eye and the modulation of pathologic angiogenesis and lymphangiogenesis to treat or prevent ocular diseases.
More information can be found in the following web-pages on e.g.:
- Modulation of corneal transplant immunology by targeting pathologic hemangiogenesis and lymphangiogenesis (laboratory Dr. F. Bock, Prof. C. Cursiefen)
- Modulation of ocular surface inflammation to treat and prevent dry eye disease and GvHD (laboratory Prof. Dr. P. Steven).
- CORIC: Cologne ophthalmological reading imaging centre: specialisation in morphologic analyses of anterior segment vascular diseases (Dr. F. Bock, Prof. Dr. C. Cursiefen)
- CIRCL: Cologne image reading centre and laboratory: specialist in morphologic analyses of retinal and choroidal vascular diseases (Prof. Dr. Liakopoulos)
- Experimental immunology of the eye: targeting of microglial cells to treat ocular diseases (Prof. Dr. T. Langmann, see more information on the web-page).
Claus Cursiefen, MD, Chairman of the Department of General Ophthalmology, Professor of Ophthalmology
Thomas Langmann, PHD, Professor of experimental immunology of the eye